Laevolac

Lactulose, the active ingredient in Laevolac, is an osmotic laxative presented as a liquid for oral use. It treats constipation and hepatic encephalopathy by drawing water into the colon and reducing ammonia absorption, and is employed in adult and pediatric patients as appropriate. It is indicated for short‑term relief of constipation and for long‑term management of hepatic encephalopathy, helping to lower blood ammonia levels and improve neurological status.

GNH USA supplies Laevolac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality assurance, regulatory compliance and reliable logistics across multiple markets.

Laevolac (lactulose) is used to manage conditions related to bowel motility and ammonia accumulation.

- Constipation: softens stools and promotes regular bowel movements by increasing colonic water content. - Hepatic encephalopathy: lowers blood ammonia levels by acidifying the colon, facilitating ammonia trapping and excretion. - Prevention of hepatic encephalopathy recurrence: maintains low ammonia concentrations to reduce the risk of episodic neurocognitive decline.

Lactulose may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Flatulence: increased gas production in the colon. - Abdominal cramps: intermittent discomfort or pain. - Diarrhea: loose stools, especially with higher doses.

Serious or Rare Side Effects: - Severe electrolyte imbalance: hyponatremia or hypokalemia. - Severe dehydration: excessive fluid loss leading to hypotension. - Allergic reaction: rash, urticaria, or angioedema.

When prescribing Laevolac, clinicians should consider several safety measures.

- Dose titration: adjust dose based on stool frequency and consistency. - Electrolyte monitoring: check serum electrolytes in patients with renal impairment or on diuretics. - Renal function assessment: use cautiously in severe renal failure. - Diabetes monitoring: lactulose may affect blood glucose; monitor levels. - Discontinuation: avoid abrupt cessation to prevent rebound constipation. - Store at ambient temperature: keep in original container, protect from moisture and light.

Lactulose can interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid): - Antidiarrheal agents (e.g., loperamide): may counteract lactulose’s laxative effect. - Mineral oil: can interfere with lactulose’s action and absorption.

Moderate Interactions (Monitor Closely): - Broad‑spectrum antibiotics: may alter gut flora and affect lactulose metabolism. - Diabetes medications: monitor blood glucose as lactulose can affect glycemic control. - Loop diuretics: increased risk of electrolyte disturbances; monitor electrolytes.